Edition:
United Kingdom

Acadia Pharmaceuticals Q1 Loss Per Share $0.59


Wednesday, 1 May 2019 

May 1 (Reuters) - ACADIA Pharmaceuticals Inc ::ACADIA PHARMACEUTICALS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.59.Q1 SALES $63 MILLION VERSUS REFINITIV IBES ESTIMATE OF $60.7 MILLION.SEES FY 2019 SALES $280 MILLION TO $300 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.52 -- REFINITIV IBES DATA.ACADIA PHARMACEUTICALS - AT MARCH 31, 2019, CASH, CASH EQUIVALENTS, & INVESTMENT SECURITIES TOTALED $414.3 MILLION, COMPARED TO $473.5 MILLION AT DEC 31, 2018.FY2019 REVENUE VIEW $291.2 MILLION -- REFINITIV IBES DATA.